Generic Pharmaceutical Stocks List

Related ETFs - A few ETFs which own one or more of the above listed Generic Pharmaceutical stocks.

Generic Pharmaceutical Stocks Recent News

Date Stock Title
May 9 ABT Drugmaker Abbott India posts Q4 profit rise on higher sales
May 9 ABT Amazon, Abbott Laboratories And 2 Other Stocks Insiders Are Selling
May 9 TEVA Teva Pharmaceutical Industries First Quarter 2024 Earnings: Revenues Beat Expectations, EPS Lags
May 9 TEVA Teva Pharmaceutical: 6 Takeaways From Q1 2024 Earnings Results
May 9 BHC Salix Pharmaceuticals announces Bellamy Young as Spokesperson for Xifaxan(R) (rifaximin)
May 9 TEVA Teva and Medincell report positive data for TEV-‘749 in schizophrenia trial
May 9 TEVA Teva: Sustained Revenue Growth Amid Financial Strain (Rating Downgrade)
May 9 ABT Insider Sale: Executive Vice President Lisa Earnhardt Sells 22,852 Shares of Abbott ...
May 8 TEVA Teva Pharmaceutical Industries (TEVA) Q1 2024 Earnings Call Transcript
May 8 TEVA Teva Pharmaceutical Industries Limited (TEVA) Q1 2024 Earnings Call Transcript
May 8 TEVA Teva hits a five-year high on schizophrenia trial win, Q1 beat
May 8 TEVA Teva Pharmaceutical Industries (TEVA) Q1 Earnings: How Key Metrics Compare to Wall Street Estimates
May 8 TEVA Teva Surges To 5-Year High On Maintained Outlook Despite Mixed First Quarter
May 8 TEVA Teva Pharmaceutical Industries Limited 2024 Q1 - Results - Earnings Call Presentation
May 8 TEVA UPDATE 1-Teva Pharm Q1 profit misses estimates, revenue risea
May 8 TEVA Teva, Medincell succeed in late-stage trial for injectable schizophrenia therapy
May 8 TEVA Teva Pharm Q1 profit misses estimates, revenue risea
May 8 ABT Got $1,000? 3 Dividend Stocks to Buy and Hold Forever
May 8 TEVA Teva Pharmaceutical reports mixed Q1 results; reaffirms FY24 outlook
May 8 TEVA Teva Reports First Quarter 2024 Financial Results and Reaffirms 2024 Financial Outlook
Generic Pharmaceutical

Generic pharmaceuticals are medications that are produced and distributed without a brand name. They are typically sold at a lower cost than brand-name drugs and are identical in terms of dosage, safety, strength, quality, performance, and intended use. Generic drugs are approved by the U.S. Food and Drug Administration (FDA) and are considered to be as safe and effective as brand-name drugs.

Browse All Tags